miR-4431 targets TRIP10/PRKD1 and impairs glucose metabolism.
Chongge PanMenghuan LiJingzhou WangXiaolong ChuJianyu XiongXin YangYihan TangDingling MaChenggang YuanJiaojiao ZhuYongsheng ChangJun ZhangCuizhe WangPublished in: Journal of diabetes investigation (2021)
miR-4431 targets TRIP10/PRKD1 and impairs glucose metabolism.